CTRI/2023/04/051367Not yet recruitingPhase 4
A comparative evaluation of hyperbaric ropivacaine (0.75%) Versus hyperbaric bupivacaine (0.5%) in patients undergoing elective caesarian section under spinal anaesthesia: A prospective randomized study
MGM Medical College and Hospital Aurangabad0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Pregnant Females between age 18 to 40 years.
- •2. Patients belonging to ASA grade 1 and 2.
- •3. Elective Caesarian Section under Spinal Anaesthesia.
- •4. Subjects willing to sign informed consent for participation in study.
Exclusion Criteria
- •1. Subjects with suspected inability to comply with the study procedure.
- •2. Patients under going caesearian section for fetal distress , Hypertensive disorders of
- •pregnancy and antepartum haemorrhage.
- •3. Known allergy to the study drug
- •4. History of Liver, Renal & Cardiac diseases.
- •5. BMI >3
Investigators
Similar Trials
Not yet recruiting
Phase 4
A comparative study between ropivacaine versus levobupivacaine for spinal anaesthesiaCTRI/2024/05/067639Dr Sunil chiruvella
Not yet recruiting
Not Applicable
Comparison between hyperbaric Ropivacaine and hyperbaric Bupivacaine in patients undergoing inguinal and perineal surgeries under spinal anaesthesia.CTRI/2023/02/050035Dr D Y Patil Medical college Hospital and Research Centre Pune
Not yet recruiting
Phase 4
Comparison of two spinal anesthesia drug in lower limb orthopedic surgeriesCTRI/2024/02/062702MGM Medical College and Hospital Aurangabad
Not yet recruiting
Unknown
Comparing ropivacaine and bupivacaine effects in spinal anaesthesia for caesarean deliveryCTRI/2023/12/060530Department of Anaesthesiology
Not yet recruiting
Phase 4
Comparision of 2 drugs( hyperbaric bupivacaine and hyperbaric ropivacaine) used in spinal anaesthesia for caeserean section in patients with pregnancy induced hypertensioCTRI/2023/11/060021RAJESHKUMAR